Since DIDS and H2DIDS were capable of inhibiting c-Met activation at relatively low concentrations and no previous in vivo data on these compounds has been reported to our knowledge, we performed a preliminary experiment in a mouse model of breast cancer to determine if DIDS could be tolerated in vivo. This evidence concerns the gene MET and breast cancer.